Skip to main content

Bolus Administration of Zidovudine During Pregnancy

  • Chapter

Abstract

This paper does not directly address the question of bolus tocolytic therapy. It examines the relative advantages of continuous intravenous infusion vs bolus oral administration of zidovudine (ZDV), previously known as azidothymidine (AZT) in the treatment of the HIV-infected woman during pregnancy. In an attempt to evaluate these two modes of therapy without risk to the mother and the intrauterine patient, we have studied the placental transfer and metabolism of the drug using an in vitro perfusion technique. Schneider and Proegler have used in vitro perfusion to compare bolus and continuous administration of beta-adrenergic antagonists (5).

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   59.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Liebes L, Mendoza S, Wilson D, Dancis J (1990) Transfer of zidovudine ( AZT) by human placenta. J Infect Dis 161: 203–207

    Article  PubMed  CAS  Google Scholar 

  2. Liebes L, Mendoza S, Lee JD, Dancis J (1992) Further observations on zidovudine (AZT) transfer and metabolism of human placenta: Estimates of fetal serum concentrations from a perfusion model. (Submitted)

    Google Scholar 

  3. Lopez-Anaza A, Unadkat JD, Schuman LA, Smith AL (1990) Pharmacokinetics of zidovudine (azidothymindine) 1. Transplacental transfer. J Acquired Immune Deficiency Syndromes 3: 959–964

    Google Scholar 

  4. O’Sullivan MJ, Boyer P, Scott G, Parks W, Weller S, Blum M R, Balskey J, Gillespie S, Mitchel C, Bryson YT (1992) A phase 1 study of the pharmacokinetics and safety of zidovudine in third trimester HIV-1 infected pregnant women and their infants. Pediat Res 31: 173A

    Google Scholar 

  5. Schneider H, Proegler M (1988) Placental transfer of beta-adrenergic antagonist studied in an in vitro perfusion system of human placental tissue. Am J Obstet Gynecol 159: 42–47

    PubMed  CAS  Google Scholar 

  6. Schuman P, Kauffman R, Crane LR, Philpot D (1990) Pharmacokinetics of zidovudine (ZDV) during pregnancy. Int. Congress on AIDS, San Francisco Abstract F 13. 17

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG Darmstadt

About this chapter

Cite this chapter

Dancis, J. (1993). Bolus Administration of Zidovudine During Pregnancy. In: Spätling, L., Fallenstein, F. (eds) Bolustokolyse in Theorie und Praxis. Steinkopff. https://doi.org/10.1007/978-3-642-72493-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72493-0_7

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-72494-7

  • Online ISBN: 978-3-642-72493-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics